Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Low levels of antibodies against phosphorylcholine in Alzheimer's disease.

Eriksson UK, Sjöberg BG, Bennet AM, de Faire U, Pedersen NL, Frostegård J.

J Alzheimers Dis. 2010;21(2):577-84. doi: 10.3233/JAD-2010-091705.

PMID:
20571218
2.

Low levels of IgM antibodies against phosphorylcholine predict development of acute myocardial infarction in a population-based cohort from northern Sweden.

Grönlund H, Hallmans G, Jansson JH, Boman K, Wikström M, de Faire U, Frostegård J.

Eur J Cardiovasc Prev Rehabil. 2009 Jun;16(3):382-6. doi: 10.1097/HJR.0b013e32832a05df.

PMID:
19369878
3.

Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: effects on uptake of oxidized LDL in macrophages as a potential mechanism.

de Faire U, Su J, Hua X, Frostegård A, Halldin M, Hellenius ML, Wikström M, Dahlbom I, Grönlund H, Frostegård J.

J Autoimmun. 2010 Mar;34(2):73-9. doi: 10.1016/j.jaut.2009.05.003. Epub 2009 Sep 2.

PMID:
19726160
4.

Low levels of IgM antibodies against phosphorylcholine-A increase mortality risk in patients undergoing haemodialysis.

Carrero JJ, Hua X, Stenvinkel P, Qureshi AR, Heimbürger O, Bárány P, Lindholm B, Frostegård J.

Nephrol Dial Transplant. 2009 Nov;24(11):3454-60. doi: 10.1093/ndt/gfp309. Epub 2009 Jun 23.

PMID:
19549697
5.

Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer's disease.

Silajdžić E, Björkqvist M, Hansson O.

BMC Neurol. 2015 Feb 5;15:8. doi: 10.1186/s12883-015-0260-1.

6.

Low level natural antibodies against phosphorylcholine: a novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease.

Frostegård J.

Clin Immunol. 2010 Jan;134(1):47-54. doi: 10.1016/j.clim.2009.08.013. Epub 2009 Sep 11. Review.

PMID:
19748321
7.

Patients with polycystic ovary syndrome have lower levels of IgM anti-phosphorylcholine antibodies than healthy women.

Gingnell M, Dahlbom I, Lindholm A, Hudecova M, Arnadottir R, Hansson T, Sundstrom-Poromaa I.

Gynecol Endocrinol. 2011 Jul;27(7):486-90. doi: 10.3109/09513590.2010.501880. Epub 2010 Jul 21.

PMID:
20645890
8.

Relationship of anti-60 kDa heat shock protein and anti-cholesterol antibodies to cardiovascular events.

Veres A, Füst G, Smieja M, McQueen M, Horváth A, Yi Q, Bíró A, Pogue J, Romics L, Karádi I, Singh M, Gnarpe J, Prohászka Z, Yusuf S; Heart Outcomes Prevention Evaluation (HOPE) Study Investigators.

Circulation. 2002 Nov 26;106(22):2775-80.

PMID:
12451002
9.

Relationship between serum insulin-like growth factor-1 levels and Alzheimer's disease and vascular dementia.

Watanabe T, Miyazaki A, Katagiri T, Yamamoto H, Idei T, Iguchi T.

J Am Geriatr Soc. 2005 Oct;53(10):1748-53.

PMID:
16181175
10.

Natural antibodies against phosphorylcholine as potential protective factors in SLE.

Su J, Hua X, Concha H, Svenungsson E, Cederholm A, Frostegård J.

Rheumatology (Oxford). 2008 Aug;47(8):1144-50. doi: 10.1093/rheumatology/ken120. Epub 2008 Jun 3. Erratum in: Rheumatology (Oxford). 2008 Oct;47(10):1593.

PMID:
18522961
11.

Natural antibodies against phosphorylcholine in cardiovascular disease.

de Faire U, Frostegård J.

Ann N Y Acad Sci. 2009 Sep;1173:292-300. doi: 10.1111/j.1749-6632.2009.04748.x. Review.

PMID:
19758165
12.

IgM antibodies against apoptotic cells and phosphorylcholine in patients with acute myocardial infarction in relation to infarct size and inflammatory response.

Diepenhorst GM, Ciurana CL, Diaz Padilla N, Boekholdt SM, Krijnen PA, Lagrand WK, Niessen HW, Hack CE.

Adv Clin Exp Med. 2012 Jul-Aug;21(4):455-67.

13.

The effect of education on the incidence of dementia and Alzheimer's disease in the Framingham Study.

Cobb JL, Wolf PA, Au R, White R, D'Agostino RB.

Neurology. 1995 Sep;45(9):1707-12.

PMID:
7675231
14.

High prevalence of Chlamydia pneumoniae antibodies and increased high-sensitive C-reactive protein in patients with vascular dementia.

Yamamoto H, Watanabe T, Miyazaki A, Katagiri T, Idei T, Iguchi T, Mimura M, Kamijima K.

J Am Geriatr Soc. 2005 Apr;53(4):583-9.

PMID:
15817002
15.

Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia.

Launer LJ, Andersen K, Dewey ME, Letenneur L, Ott A, Amaducci LA, Brayne C, Copeland JR, Dartigues JF, Kragh-Sorensen P, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A.

Neurology. 1999 Jan 1;52(1):78-84.

PMID:
9921852
16.

Alzheimer's disease or other dementia and medical care utilization.

Eaker ED, Mickel SF, Chyou PH, Mueller-Rizner NJ, Slusser JP.

Ann Epidemiol. 2002 Jan;12(1):39-45.

PMID:
11750239
17.

Low serum VEGF levels are associated with Alzheimer's disease.

Mateo I, Llorca J, Infante J, Rodríguez-Rodríguez E, Fernández-Viadero C, Peña N, Berciano J, Combarros O.

Acta Neurol Scand. 2007 Jul;116(1):56-8.

PMID:
17587256
18.

[A case-control study on the risk factors of Alzheimer's disease in military elderly men].

Chang Q, He Y, Ni B, Feng K, Jiang Y, Jiang B.

Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Oct;25(10):890-3. Chinese.

PMID:
15631750
19.

Low levels of antibodies against phosphorylcholine predict development of stroke in a population-based study from northern Sweden.

Fiskesund R, Stegmayr B, Hallmans G, Vikström M, Weinehall L, de Faire U, Frostegård J.

Stroke. 2010 Apr;41(4):607-12. doi: 10.1161/STROKEAHA.109.558742. Epub 2010 Feb 11.

PMID:
20150554
20.

Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort.

Newman AB, Fitzpatrick AL, Lopez O, Jackson S, Lyketsos C, Jagust W, Ives D, Dekosky ST, Kuller LH.

J Am Geriatr Soc. 2005 Jul;53(7):1101-7.

PMID:
16108925

Supplemental Content

Support Center